KALA BIO, Inc.
KALA • NASDAQ
KALA BIO, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Avi Minkowitz, with a market cap of $166.8M.
Market Cap$166.8M
Employees43.0
CEOAvi Minkowitz
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
KAL
KALA BIO, Inc. FAQ
Common questions about KALA BIO, Inc.
KALA BIO, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
KALA BIO, Inc. has approximately 43 employees.